Volume 8, Issue 5
Editorialp. 507
Progenitor cell therapies as a novel treatment for traumatic brain injury: a pathway towards neuroprotection
Author(s): Peter A Walker, Shinil K Shah and Charles S Cox Jr
Review Articlep. 527
Tenofovir in the treatment of chronic hepatitis B
Author(s): Derek Yu and Jenny Heathcote
Research Articlep. 545
Comparison of the therapeutic efficacy of 0.1% olopatadine hydrochloride and 0.025% ketotifen fumarate in allergic conjunctivitis
Author(s): Shah-Jalal Sarker, Abu Nayeem Chowdhury, Zahid Hussain, AKM Mosharrof Hossain and Hashem Chowdhury
Research Articlep. 555
Rebound tonometry for the measurement of intraocular pressure and its relation with gender and refractive errors in Mozambique
Author(s): Javier Ruiz-Alcocer, David Madrid-Costa, Caridad Perez-Vives, Santiago Garcia-Lazaro and Jorge Jorge
Review Articlep. 563
Antimalarial drug combination chemotherapy in malaria case management in Tanzania: how did it come about?
Author(s): Stephen ED Nsimba
Review Articlep. 569
The spectrum of albuminuria as a predictor of cardiorenal outcomes
Author(s): Ivana Lazich, and George L Bakris
Appendicesp. 582
Author guidelines: Volume 8 Issue 5
Appendicesp. 581
Acknowledgement: Volume 8 Issue 5
Forewordp. 457
Alzheimer\'s disease therapy: a moving target
Author(s): Rudy J Castellani, Xiongwei Zhu and George Perry
Perspectivep. 491
Current and future treatments of memory complaints and Alzheimer\'s disease
Author(s): William K Summers
Review Articlep. 481
Repositioning leptin as a therapy for Alzheimer\'s disease
Author(s): Jane M Johnston, Steven J Greco, Ashkan Hamzelou, J Wesson Ashford and Nikolaos Tezapsidis
Review Articlep. 475
Pathological phenotype in familial neurodegenerative disease: implications for families and therapeutic constructs
Author(s): Rudy J Castellani, Hyoung-gon Lee, Robert B Petersen, Xiongwei Zhu and George Perry
Research Highlightsp. 471
Highlights from the latest articles in Alzheimer\'s disease
Author(s): Jesus Avila and Carmen Laura Sayas
News and Viewsp. 467
Alzheimer\'s Disease
Editorialp. 463
The vasculature in Alzheimer\'s disease: a new therapeutic target for an old disease?
Author(s): Paula Grammas
Editorialp. 459
Why age (and timing) really matters in developing drugs for neurodegenerative disease
Author(s): Dave Morgan and Amanda G Smith
